Data protection-compliant ways to use real world data

被引:0
|
作者
Drepper, Johannes [1 ]
机构
[1] TMF Technol & Methodenplattform Vernetzte Med For, Berlin, Germany
关键词
Data protection law; Informed consent; Technical and organisational measures; Pseudonymization; Anonymization;
D O I
10.1007/s11553-022-00991-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The secondary use of existing real world data is seen as a promising method of medical research that complements the conduct of closely controlled studies. However, these real world data are collected in very different situations and are therefore subject to heterogeneous framework conditions in terms of data protection. Objectives Supporting the privacy-compliant use of real world data. Materials and methods In addition to general data protection laws at the European, national, and state levels, areas of law specific to health data, such as medical confidentiality or social law, are also examined. Protection methods such as pseudonymization and anonymization are examined and classified. Results The processing of real world data usually leads to the application of data protection law. Clarifying responsibility under data protection law can be challenging in complex collaborative projects. The type of possible legal basis for processing depends on specific framework conditions as well as the type of processing. In addition, the data must be protected during processing by technical and organizational measures. Conclusions The data protection legal framework for the processing of real world data is complex. Simplification and harmonization have not even been achieved within Germany with the European General Data Protection Regulation. Certain ways of using this data, e.g., on the basis of broad consent or with the help of an agreed assessment in accordance with a research clause, involve a great deal of effort and expense and are thus generally only available to larger projects or infrastructures.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] For insights into the real world, consider real-world data
    Raoof, Sana
    Kurzrock, Razelle
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (673)
  • [32] Privacy and data protection in the enterprise world
    Imtiyazuddin Shaik
    Nishanth Chandran
    Rajan M. A
    CSI Transactions on ICT, 2022, 10 (1) : 37 - 45
  • [33] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [34] REAL WORLD EVIDENCE: PROMISE AND PITFALLS OF REAL WORLD DATA
    Weir, S.
    Langham, S.
    Ratcliffe, M.
    VALUE IN HEALTH, 2012, 15 (07) : A465 - A466
  • [35] Drug use research in Peru: Is real-world data available?
    Rodriguez, Yesenia
    Salas, Maribel
    Leal, Lisiane
    Monique, Monique
    Lopes, Luciane Cruz
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 168 - 169
  • [36] Use of real world data to improve drug coverage decisions in China
    Wang, Wen
    Tan, Jing
    Wu, Jing
    Huang, Shiyao
    Huang, Yunxiang
    Xie, Feng
    Sun, Xin
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [37] The use of real-world data to address questions of patient safety
    Yates, Mark
    Bechman, Katie
    Galloway, James
    RHEUMATOLOGY, 2020, 59 (01) : 26 - 30
  • [38] Use of real-world registry data: a hernia mesh example
    Lee, T. -H.
    Choudhuri, A.
    Ulisney, K.
    Swiger, J.
    Poulose, B.
    Rosen, M.
    Gibeily, G.
    HERNIA, 2020, 24 (03) : 587 - 590
  • [39] Put Your Data to Use: Entering the Real World of Children and Families
    Hirsh-Pasek, Kathy
    Golinkoff, Roberta Michnick
    PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, 2019, 14 (01) : 37 - 42
  • [40] Real-World Data: Policy Issues Regarding their Access and Use
    Basu, Anirban
    Axelsen, Kirsten
    Grabowski, David C.
    Meltzer, David O.
    Polsky, Daniel
    Ridley, David B.
    Wiederkehr, Daniel
    Philipson, Tomas J.
    MEDICAL CARE, 2016, 55 (12) : 1038 - 1044